Vice Director Yu Jun of Hangzhou Science and Technology Bureau and his delegation visited Xingyue Biotechnology for research and guidance
On the afternoon of August 6th, Yu Jun, Deputy Director of Hangzhou Science and Technology Bureau, led a team to visit Xingyue Biotechnology for research and guidance, to gain a deeper understanding of the innovative achievements and industrialization progress of enterprises in the field of biomedical materials. Chen Xiyang, Director of the Achievements Department of Hangzhou Science and Technology Bureau, and relevant department heads of the District Science and Technology Bureau accompanied the inspection. Zhao Hongshi, General Manager of Xingyue Biotechnology, and Chen Longkun, Deputy General Manager, warmly received it.
Accompanied by the management team of Xingyue Biotechnology, Deputy Director Yu Jun and his delegation visited the enterprise industry transformation center, research and development laboratory, and product exhibition center, focusing on the research and industrialization of the new biomaterial medical silk. They also had in-depth exchanges on the extraction process, product performance, and market prospects of silk fibroin materials.
At the symposium, General Manager Zhao Hongshi expressed gratitude to the leaders of the city and district science and technology bureaus for their long-term care and support, and gave a detailed report on the company's development history, technological innovation achievements, and future development plans. He introduced that under the policy guidance of supporting the innovative development of the "cocoon silk" industry in the country, Xingyue Biotechnology has taken silk fibroin materials as its strategic pivot, and through continuous technological innovation and industrial chain layout, has successfully built a product matrix covering medical silk raw materials, high-end medical equipment, medical beauty, and functional skincare. Enterprises rely on the advantages of innovation platforms such as provincial key laboratories and key enterprise research institutes to actively participate in the application for major science and technology projects and the formulation of industry standards at the provincial and municipal levels. General Manager Zhao Hongshi also had in-depth discussions with the research team on the challenges currently faced by the company in terms of research and development support, market promotion, and talent introduction.
Deputy Director Yu Jun fully affirmed the innovative achievements of Xingyue Biotechnology in the field of medical silk materials, and also put forward earnest expectations for the development of the enterprise. He pointed out that Hangzhou has established a gradient cultivation system of "technology-based small and medium-sized enterprises - high-tech enterprises - new fledgling enterprises - technology leading enterprises", forming an innovation and entrepreneurship service system covering the entire life cycle of enterprises. He emphasized that technological innovation is the core engine driving high-quality economic development, and the leading role of technological innovation in industrial upgrading should be fully utilized. The government will continue to optimize the business environment and develop precise support plans based on the development needs of enterprises. Strengthen policy protection and increase support for enterprise technological breakthroughs and achievement transformation; Optimize technology services and smooth communication channels between government and enterprises; Attract and cultivate high-level talents to provide intellectual support for the innovative development of enterprises; Promote the deep integration of industry, academia and research, and bridge the "last mile" from laboratory to industrialization.
In the future, Xingyue Biotechnology will always adhere to the innovation driven development strategy, focusing on the in-depth research and industrial application of medical silk materials, continuously strengthening R&D investment, and accelerating the pace of scientific and technological achievements transformation. Enterprises will actively integrate into the technology innovation system of Hangzhou, deepen industry university research cooperation with universities, and make greater contributions to promoting the high-quality development of Hangzhou's biopharmaceutical industry.
